B-Cell-Specific Myd88 L252P Expression Causes a Premalignant Gammopathy Resembling IgM MGUS
出版年份 2020 全文链接
标题
B-Cell-Specific Myd88 L252P Expression Causes a Premalignant Gammopathy Resembling IgM MGUS
作者
关键词
-
出版物
Frontiers in Immunology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-12-01
DOI
10.3389/fimmu.2020.602868
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas
- (2020) Manit Munshi et al. Blood Cancer Journal
- How I treat Waldenström's Macroglobulinemia
- (2019) Meletios A Dimopoulos et al. BLOOD
- Pathogenic B‐cell receptor signaling in lymphoid malignancies: New insights to improve treatment
- (2019) Ryan M. Young et al. IMMUNOLOGICAL REVIEWS
- Detection of MYD88 L265P mutation by next-generation deep sequencing in peripheral blood mononuclear cells of Waldenström’s macroglobulinemia and IgM monoclonal gammopathy of undetermined significance
- (2019) Ayako Nakamura et al. PLoS One
- MYD88L265P Mutation in Lymphoid Malignancies
- (2018) Xinfang Yu et al. CANCER RESEARCH
- A multiprotein supercomplex controlling oncogenic signalling in lymphoma
- (2018) James D. Phelan et al. NATURE
- Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance
- (2018) Robert A. Kyle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia
- (2018) Alessandra Tedeschi et al. HEMATOLOGICAL ONCOLOGY
- Waldenström macroglobulinemia: 2019 update on diagnosis, risk stratification, and management
- (2018) Morie A. Gertz AMERICAN JOURNAL OF HEMATOLOGY
- The PRIDE database and related tools and resources in 2019: improving support for quantification data
- (2018) Yasset Perez-Riverol et al. NUCLEIC ACIDS RESEARCH
- Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma
- (2018) Kerstin Wenzl et al. Blood Cancer Journal
- Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance
- (2017) Marzia Varettoni et al. HAEMATOLOGICA
- Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis
- (2017) Ju-Han Lee et al. Scientific Reports
- Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance
- (2017) Marzia Varettoni et al. HAEMATOLOGICA
- Diagnosis and Management of Waldenström Macroglobulinemia
- (2017) Prashant Kapoor et al. JAMA Oncology
- B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice
- (2016) G. Knittel et al. BLOOD
- Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenström macroglobulinemia
- (2016) Zachary R. Hunter et al. BLOOD
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia
- (2016) Jorge J. Castillo et al. BRITISH JOURNAL OF HAEMATOLOGY
- Negative regulation of NF-κB p65 activity by serine 536 phosphorylation
- (2016) Jean-Philippe Pradère et al. Science Signaling
- Negative regulation of NF-κB p65 activity by serine 536 phosphorylation
- (2016) Jean-Philippe Pradère et al. Science Signaling
- The cellular origin and malignant transformation of Waldenstrom macroglobulinemia
- (2015) B. Paiva et al. BLOOD
- Clonal architecture ofCXCR4WHIM-like mutations in Waldenström Macroglobulinaemia
- (2015) Lian Xu et al. BRITISH JOURNAL OF HAEMATOLOGY
- MYD88L265P andCXCR4mutations in lymphoplasmacytic lymphoma identify cases with high disease activity
- (2015) Janine Schmidt et al. BRITISH JOURNAL OF HAEMATOLOGY
- Genomic Landscape of CXCR4 Mutations in Waldenstro m Macroglobulinemia
- (2015) S. Poulain et al. CLINICAL CANCER RESEARCH
- The B-cell antigen receptor integrates adaptive and innate immune signals
- (2015) Kevin L. Otipoby et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma
- (2014) A. M. Roccaro et al. BLOOD
- Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia
- (2014) S. P. Treon et al. BLOOD
- Activation of lymphoma-associated MyD88 mutations via allostery-induced TIR-domain oligomerization
- (2014) M. Avbelj et al. BLOOD
- Consequences of the recurrentMYD88L265Psomatic mutation for B cell tolerance
- (2014) James Q. Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
- (2014) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Detection of MYD88 L265P in peripheral blood of patients with Waldenström’s Macroglobulinemia and IgM monoclonal gammopathy of undetermined significance
- (2014) L Xu et al. LEUKEMIA
- Outcome Disparities among Ethnic Subgroups of Waldenström's Macroglobulinemia: A Population-Based Study
- (2014) Sikander Ailawadhi et al. ONCOLOGY
- A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenstrom macroglobulinemia
- (2013) G. Yang et al. BLOOD
- MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance
- (2013) M. Varettoni et al. BLOOD
- MYD88 L265P mutation in Waldenstrom macroglobulinemia
- (2013) S. Poulain et al. BLOOD
- Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms
- (2013) M. Varettoni et al. BLOOD
- The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis
- (2013) Z. R. Hunter et al. BLOOD
- MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction
- (2013) L. Xu et al. BLOOD
- MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström’s macroglobulinemia
- (2013) C Jiménez et al. LEUKEMIA
- Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors
- (2013) Marzia Varettoni et al. LEUKEMIA & LYMPHOMA
- IgBLAST: an immunoglobulin variable domain sequence analysis tool
- (2013) Jian Ye et al. NUCLEIC ACIDS RESEARCH
- Progression in smoldering Waldenstrom macroglobulinemia: long-term results
- (2012) R. A. Kyle et al. BLOOD
- Differential Diagnosis of IgM MGUS and WM According to B-Lymphoid Infiltration by Morphology and Flow Cytometry
- (2012) Enrique M. Ocio et al. Clinical Lymphoma Myeloma & Leukemia
- MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia
- (2012) Steven P. Treon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
- (2011) Jürgen Cox et al. JOURNAL OF PROTEOME RESEARCH
- IgM multiple myeloma: Disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia
- (2010) Steven R. Schuster et al. AMERICAN JOURNAL OF HEMATOLOGY
- Oncogenically active MYD88 mutations in human lymphoma
- (2010) Vu N. Ngo et al. NATURE
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
- (2009) O. Landgren et al. BLOOD
- Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor- B Signaling Pathways in Waldenstrom's Macroglobulinemia
- (2009) E. Braggio et al. CANCER RESEARCH
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
- (2008) Jürgen Cox et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now